Cargando…
Identification of the Novel Methylated Genes' Signature to Predict Prognosis in INRG High-Risk Neuroblastomas
BACKGROUND: Neuroblastomas are the most frequent extracranial pediatric solid tumors. The prognosis of children with high-risk neuroblastomas has remained poor in the past decade. A powerful signature is required to identify factors associated with prognosis and improved treatment selection. Here, w...
Autores principales: | Liu, Zhichao, Li, Changchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455188/ https://www.ncbi.nlm.nih.gov/pubmed/34557229 http://dx.doi.org/10.1155/2021/1615201 |
Ejemplares similares
-
Retracted: Identification of the Novel Methylated Genes' Signature to Predict Prognosis in INRG High-Risk Neuroblastomas
por: Osteoporosis, Journal of
Publicado: (2022) -
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
por: Ambros, P F, et al.
Publicado: (2009) -
Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months
por: Fischer, Janina, et al.
Publicado: (2017) -
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
por: Schleiermacher, G, et al.
Publicado: (2012) -
Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force
por: Matthay, K K, et al.
Publicado: (2010)